July 10, 2007
FDA Requirements Do Not Preempt Failure-to-Warn Claims
As reported in the International Herald Tribune, a U.S. district court judge held last week that FDA approval of drug labels does not preempt state-law claims for failure-to-warn. As noted in a prior post, the U.S. Supreme Court recently granted cert. in a similar case involving medical devices.
TrackBack URL for this entry:
Listed below are links to weblogs that reference FDA Requirements Do Not Preempt Failure-to-Warn Claims: